🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to demonstrate the clinical efficacy and safety of the nano...
Status
Completed
Location
Clinical Site
Start Date
2022-12-13
Trial ID
NCT05640245
Treatments Being Tested
This is a multi-center phase 2b study in subjects with moderate to severe c...
Status
Completed
Location
Investigative Site
Start Date
2018-07-31
Trial ID
NCT03384745
Treatments Being Tested
This is a study to demonstrate the long-term safety, tolerability and clini...
Status
Enrolling By Invitation
Location
Clinical Site
Start Date
2025-11-13
Trial ID
NCT07223138
Treatments Being Tested
This is a study to demonstrate the clinical efficacy and safety of soneloki...
Status
Active Not Recruiting
Location
Clinical Site
Start Date
2024-10-15
Trial ID
NCT06641076
Treatments Being Tested
This is a study to evaluate the clinical efficacy and safety of sonelokimab...
Status
Completed
Location
Clinical Site
Start Date
2024-05-14
Trial ID
NCT06411379
Treatments Being Tested
This is a study to evaluate the clinical efficacy and safety of sonelokimab...
Status
Completed
Location
Clinical Site
Start Date
2024-05-15
Trial ID
NCT06411899
Treatments Being Tested
This is a study to evaluate the long-term safety, tolerability, and efficac...
Status
Enrolling By Invitation
Location
Clinical Site
Start Date
2025-06-27
Trial ID
NCT07007637
Treatments Being Tested
This is a study to demonstrate the clinical efficacy and safety of the nano...
Status
Completed
Location
Clinical Site
Start Date
2022-04-25
Trial ID
NCT05322473
Treatments Being Tested
This is a study to evaluate the pharmacokinetic (PK) and safety of soneloki...
Status
Active Not Recruiting
Location
Clinical Site
Start Date
2024-12-30
Trial ID
NCT06768671
Treatments Being Tested
This is a study to confirm the relative bioequivalence of sonelokimab admin...
Status
Completed
Location
Clinical Site
Start Date
2025-06-05
Trial ID
NCT06994936
Treatments Being Tested